Human Sciences Research Council, Durban, South Africa.
South African Research Ethics Training Initiative (SARETI), University of KwaZulu-Natal, Pietermaritzburg, South Africa.
Hum Vaccin Immunother. 2023 Dec 31;19(1):2179789. doi: 10.1080/21645515.2023.2179789. Epub 2023 Feb 20.
Concerns regarding the safety of COVID-19 vaccination have caused hesitancy and lowered uptake globally. While vaccine hesitancy is documented globally, some continents, countries, ethnic groups and age groups are disproportionately affected, resulting in significant global inequities. To date, Africa has the lowest COVID-19 coverage globally, with only 22% of its population completely vaccinated. It might be argued that the difficulty with COVID-19 vaccine acceptance in Africa was triggered by the anxiety created by misinformation on social media platforms, particularly with the misinformation regarding depopulating Africa, given the significance of maternity in the continent. In this work, we examine numerous determinants of poor vaccination coverage that have received little attention in primary research and that may need to be considered by various stakeholders engaged in the COVID-19 vaccine strategy at the national and continental levels. Our study also emphasizes the importance of a multidisciplinary team when introducing a new vaccine, for people to trust that the vaccine is truly helpful to them and to be convinced that immunization is, all things considered, worthwhile.
人们对接种 COVID-19 疫苗的安全性表示担忧，这在全球范围内导致了人们对接种疫苗的犹豫和抵触。尽管疫苗犹豫在全球范围内都有记录，但一些大陆、国家、族裔群体和年龄群体受到的影响不成比例，导致了严重的全球不平等。迄今为止，非洲的 COVID-19 疫苗接种覆盖率在全球最低，只有 22%的人口完全接种了疫苗。有人可能会认为，非洲人对接种 COVID-19 疫苗的抵触是由社交媒体平台上错误信息引发的焦虑所导致的，特别是关于非洲人口减少的错误信息，因为生育在非洲具有重要意义。在这项工作中，我们研究了许多在初级研究中很少受到关注的、可能需要在国家和大陆层面参与 COVID-19 疫苗战略的各个利益相关者考虑的、导致疫苗接种覆盖率低的决定因素。我们的研究还强调了在引入新疫苗时组建多学科团队的重要性，以便让人们相信疫苗对他们真正有帮助，并确信接种疫苗从各方面考虑都是值得的。
